VAIM, a leading global medical aesthetic company, successfully hosted the JUVELOOK & juveàcell Symposium in Busan at the Signiel Busan Grand Ballroom on Monday, catering to medical professionals.
The symposium was organized to provide practical insights for healthcare providers, addressing the evolving landscape of aesthetic medicine and the increasing complexity of treatment options.
The event showcased real-world clinical applications of JUVELOOK i, highlighting strategies for combining it with JUVELOOK Volume treatments. Attendees shared case studies demonstrating varied application methods and protocols tailored to specific treatment goals and target areas, offering valuable clinical insights to enhance treatment reproducibility and safety.
The symposium also introduced the new powdered JUVEÀCELL v·g products, complementing the existing liquid formulations available in 3% and 8% concentrations. Experts emphasized how this expanded product range offers greater flexibility in treatment options and enables more precise applications for both facial and body treatments.
A spokesperson for VAIM stated that this symposium has effectively demonstrated the clinical potential of JUVELOOK i through shared real-world applications and strategies for utilizing the JUVEÀCELL v·g lineup. It’s committed to expanding academic exchanges that directly benefit medical professionals in their day-to-day practice.
The representative added that it will continue to refine the treatment protocols by leveraging accumulated clinical data for each product and incorporating the shared experiences of medical professionals.
VAIM has been making waves in the aesthetic industry with its innovative skin booster, JUVELOOK.
Leveraging its advanced research and development (R&D) capabilities and robust production infrastructure, the company has developed a diverse portfolio of products. VAIM is steadily expanding its global market presence through academic collaborations and shared clinical experiences with medical professionals both in the U.S. and internationally.
Notably, VAIM has been actively hosting product launch symposiums in key international markets, including Thailand and Singapore, further strengthening its connections with the global medical community.
